title: Letter: reduction in chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low-risk patients - more questions than answers. Authors' reply.
authors.affiliation: Department of Medicine, Stanford University Medical Center, Palo Alto, CA, USA.
authors.forename: D
authors.initials: D
authors.lastname: Lin
authors.affiliation: Genomics Research Center, Academia Sinica, Taipei, Taiwan.
authors.forename: H-I
authors.initials: HI
authors.lastname: Yang
authors.affiliation: Division of GI and Hepatology, Stanford University Medical Center, Palo Alto, CA, USA.
authors.forename: J
authors.initials: J
authors.lastname: Hoang
authors.affiliation: Division of GI and Hepatology, Stanford University Medical Center, Palo Alto, CA, USA.
authors.forename: M H
authors.initials: MH
authors.lastname: Nguyen
mesh_terms: D000998:Antiviral Agents; D006528:Carcinoma, Hepatocellular; D019694:Hepatitis B, Chronic; D006801:Humans; D008113:Liver Neoplasms
chemical_list: D000998:Antiviral Agents